Edition:
India

Ben Hirschler

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

11 Dec 2017

'Ground-breaking' new drug gives hope in Huntington's disease

LONDON Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

11 Dec 2017

GSK's new pharma head on lookout for cancer deals to boost pipeline

LONDON GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.

07 Dec 2017

More than 2,000 drugs now in cancer immunotherapy race

LONDON The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.

07 Dec 2017

Roche to seize leap-frog opportunity in lung cancer

LONDON After lagging rivals in cancer immunotherapies, Swiss drugmaker Roche hopes to leap-frog into the lead in the biggest market, tackling previously untreated lung cancer.

06 Dec 2017

GSK, other drugmakers bet on post-Brexit UK science

LONDON Britain won a vote of confidence from its economically important life sciences sector on Wednesday as several major drug companies committed to invest in the country under the government's industrial strategy plans after Brexit.

05 Dec 2017

Philippines halts sale of dengue vaccine as Sanofi downplays risk

MANILA/LONDON The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country after the company last week warned it could worsen the disease in some cases. | Video

05 Dec 2017

Rats join mosquitoes as targets for 'gene drive' pest control

LONDON Rodents have joined mosquitoes in the cross-hairs of scientists working on a next-generation genetic technology known as "gene drive" to control pests.

04 Dec 2017

Poor regulation, dodgy pills spur plan for African drugs agency

LONDON Last July, Ugandan officials seized fake versions of the cancer drug Avastin on sale in Kampala, revealing only the tip of an iceberg of bogus medicines found all too often in Africa.

01 Dec 2017

Genmab and Johnson & Johnson 'love' partnership as some ponder takeover

LONDON Genmab was Europe's second biggest biotech company, until its partner Johnson & Johnson bought Switzerland's Actelion for $30 billion this year and propelled the Danish antibody specialist to the top spot.

30 Nov 2017

New vaccine, long-acting drug trials buoy hopes in HIV fight

LONDON Researchers announced the launch of two big studies in Africa on Thursday to test a new HIV vaccine and a long-acting injectable drug, fueling hopes for better ways to protect against the virus that causes AIDS.

Markets

  • Asia
  • U.S.
  • Europe
  • Sectors
Stock Search
Sensex 33,308.27 -147.52 -0.44%
Nikkei 22,944.21 + 5.48 +0.02%
Hang Seng 28,832.66 -132.63 -0.46%
EUR/INR 75.843 +0.00%
USD/INR 64.470 +0.00%
GBP/INR 86.280 -0.05%
Gold 1,245.90 -3.90 -0.31%
Oil 58.44 +0.45 +0.78%
Corn 336.00 -0.50 -0.15%